Twist Bioscience (TWST) Revenue & Revenue Breakdown
Twist Bioscience Revenue Highlights
Latest Revenue (Y)
$245.11M
Latest Revenue (Q)
$81.46M
Main Segment (Y)
Ngs Tools
Main Geography (Y)
Americas
Twist Bioscience Revenue by Period
Twist Bioscience Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $245.11M | 20.41% |
| 2022-09-30 | $203.56M | 53.83% |
| 2021-09-30 | $132.33M | 46.87% |
| 2020-09-30 | $90.10M | 65.67% |
| 2019-09-30 | $54.38M | 113.89% |
| 2018-09-30 | $25.43M | 136.16% |
| 2017-09-30 | $10.77M | 374.53% |
| 2016-09-30 | $2.27M | - |
Twist Bioscience generated $245.11M in revenue during NA 2023, up 20.41% compared to the previous quarter, and up 963.97% compared to the same period a year ago.
Twist Bioscience Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $81.46M | 8.18% |
| 2024-03-31 | $75.30M | 5.32% |
| 2023-12-31 | $71.50M | 6.80% |
| 2023-09-30 | $66.95M | 5.03% |
| 2023-06-30 | $63.74M | 5.92% |
| 2023-03-31 | $60.18M | 10.95% |
| 2022-12-31 | $54.24M | -5.34% |
| 2022-09-30 | $57.31M | 2.13% |
| 2022-06-30 | $56.11M | 16.59% |
| 2022-03-31 | $48.13M | 14.54% |
| 2021-12-31 | $42.02M | 10.72% |
| 2021-09-30 | $37.95M | 8.38% |
| 2021-06-30 | $35.02M | 12.22% |
| 2021-03-31 | $31.20M | 10.81% |
| 2020-12-31 | $28.16M | -13.17% |
| 2020-09-30 | $32.43M | 52.93% |
| 2020-06-30 | $21.21M | 9.90% |
| 2020-03-31 | $19.30M | 12.43% |
| 2019-12-31 | $17.16M | 9.07% |
| 2019-09-30 | $15.74M | 15.71% |
| 2019-06-30 | $13.60M | 0.32% |
| 2019-03-31 | $13.56M | 17.97% |
| 2018-12-31 | $11.49M | 36.70% |
| 2018-09-30 | $8.41M | 28.53% |
| 2018-06-30 | $6.54M | 6.08% |
| 2018-03-31 | $6.17M | 42.96% |
| 2017-12-31 | $4.31M | 24.44% |
| 2017-09-30 | $3.47M | - |
Twist Bioscience generated $81.46M in revenue during Q3 2024, up 8.18% compared to the previous quarter, and up 135.37% compared to the same period a year ago.
Twist Bioscience Revenue Breakdown
Twist Bioscience Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Sep 23 | Sep 22 | Sep 21 | Sep 20 | Sep 19 |
|---|---|---|---|---|---|
| Antibody Discovery | $23.17M | $24.17M | - | - | - |
| Dna And Biopharma Libraries | $10.20M | $6.15M | $12.66M | - | - |
| Ngs Tools | $123.71M | $99.31M | $72.67M | - | - |
| Oligo Pools | $14.49M | $12.42M | $8.04M | $4.54M | $4.59M |
| Synthetic Genes | $73.54M | $61.51M | $38.96M | $35.19M | $26.71M |
| DNA And Biopharma Libraries | - | - | - | $6.35M | - |
| NGS Tools | - | - | - | $44.02M | $21.04M |
| DNA Libraries | - | - | - | - | $2.04M |
Twist Bioscience's latest annual revenue breakdown by segment (product or service), as of Sep 23: Ngs Tools (50.47%), Synthetic Genes (30.00%), Antibody Discovery (9.45%), Oligo Pools (5.91%), and Dna And Biopharma Libraries (4.16%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oligo Pools | $4.17M | $3.94M | $4.19M | $3.74M | $3.73M | $3.31M | $3.70M | $3.67M | $3.26M | $2.31M | $3.19M | $2.67M | $2.02M | $1.84M | $1.51M | $1.20M | $1.00M | $1.10M | $1.24M | $1.31M |
| Synthetic Genes | $24.95M | $22.36M | $19.73M | $20.05M | $19.30M | $18.01M | $16.18M | $16.42M | $17.40M | $14.16M | $13.53M | $9.74M | $11.16M | $9.19M | $8.87M | $8.64M | $9.60M | $9.12M | $7.84M | $7.86M |
| Antibody Discovery | $5.10M | $4.70M | $5.23M | $3.39M | $4.58M | $7.03M | $8.17M | $6.53M | $6.24M | $6.59M | $4.81M | - | - | - | - | - | - | - | - | - |
| Dna And Biopharma Libraries | $3.85M | $3.53M | $2.94M | $2.66M | $2.88M | $2.83M | $1.84M | $1.50M | $1.42M | $1.97M | $1.26M | $4.10M | $3.14M | $3.22M | - | - | - | - | - | - |
| Ngs Tools | $43.40M | $40.77M | $39.42M | $37.11M | $33.24M | $28.99M | $24.36M | $29.19M | $27.79M | $23.10M | $19.23M | $21.45M | $18.70M | $16.95M | - | - | - | - | - | - |
| DNA And Biopharma Libraries | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.21M | $2.42M | $1.52M | $1.35M | - | - |
| NGS Tools | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $15.57M | $20.18M | $9.08M | $7.73M | $7.03M | $6.18M |
| DNA Libraries | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.06M | $382.00K |
Twist Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Ngs Tools (53.28%), Synthetic Genes (30.62%), Antibody Discovery (6.26%), Oligo Pools (5.11%), and Dna And Biopharma Libraries (4.72%).
Twist Bioscience Revenue Breakdown by Country
Annual Revenue by Country
| Country | Sep 23 | Sep 22 | Sep 21 | Sep 20 | Sep 19 |
|---|---|---|---|---|---|
| EMEA | $71.39M | $62.08M | $25.82M | $14.69M | - |
| Americas | $151.26M | $122.47M | $77.91M | $1.08M | - |
| Asia Pacific | $22.46M | $19.01M | $10.30M | $5.12M | $2.76M |
| E M E A | - | - | $44.12M | - | - |
| UNITED STATES | - | - | - | $58.08M | $35.94M |
| North America | - | - | - | - | $996.00K |
Twist Bioscience's latest annual revenue breakdown by geography, as of Sep 23: Americas (61.71%), EMEA (29.13%), and Asia Pacific (9.16%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific | $6.49M | $7.17M | $6.32M | $6.06M | $5.66M | $6.47M | $4.27M | $5.60M | $4.83M | $4.46M | $4.04M | $2.77M | $3.10M | $2.67M | $1.77M | $1.75M | $1.18M | $944.00K | $1.24M | $744.00K |
| Americas | $51.39M | $45.87M | $43.96M | $43.68M | $39.02M | $34.92M | $33.65M | $34.84M | $35.80M | $28.46M | $22.61M | $76.58M | $544.00K | $484.00K | $302.00K | $290.00K | $269.00K | $369.00K | - | - |
| EMEA | $23.58M | $22.26M | $21.22M | $17.21M | $19.07M | $18.78M | $16.33M | $16.87M | $15.48M | $15.20M | $9.06M | $7.25M | $6.39M | $6.23M | $5.94M | $5.43M | - | - | - | - |
| E M E A | - | - | - | - | - | - | - | - | - | - | $15.37M | $12.43M | $12.66M | $9.98M | - | - | - | - | - | - |
| U | - | - | - | - | - | - | - | - | - | - | - | - | $18.72M | $18.08M | - | - | - | - | - | - |
| UNITED STATES | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $17.03M | $23.14M | $13.37M | $11.75M | $9.83M | $9.37M |
| North America | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $155.00K | - |
Twist Bioscience's latest quarterly revenue breakdown by geography, as of Jun 24: Americas (63.08%), EMEA (28.95%), and Asia Pacific (7.97%).
Twist Bioscience Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TMO | Thermo Fisher Scientific | $42.86B | $10.54B |
| IQV | IQVIA | $14.98B | $3.81B |
| DHR | Danaher | $14.03B | $3.43B |
| ICLR | ICON Public Limited Company | $8.12B | $2.09B |
| A | Agilent | $6.83B | $1.58B |
| ILMN | Illumina | $4.50B | $1.08B |
| MTD | Mettler-Toledo | $3.79B | $946.75M |
| WAT | Waters | $2.96B | $708.53M |
| EXAS | Exact Sciences | $2.50B | $699.26M |
| NTRA | Natera | $1.08B | $413.35M |
| GH | Guardant Health | $563.95M | $177.24M |
| CDNA | CareDx | $280.32M | $92.27M |
| TWST | Twist Bioscience | $245.11M | $81.46M |
| CSTL | Castle Biosciences | $219.79M | $87.00M |
| PSNL | Personalis | $73.48M | $19.52M |
TWST Revenue FAQ
What is Twist Bioscience’s yearly revenue?
Twist Bioscience's yearly revenue for 2023 was $245.11M, representing an increase of 20.41% compared to 2022. The company's yearly revenue for 2022 was $203.56M, representing an increase of 53.83% compared to 2021. TWST's yearly revenue for 2021 was $132.33M, representing an increase of 46.87% compared to 2020.
What is Twist Bioscience’s quarterly revenue?
Twist Bioscience's quarterly revenue for Q3 2024 was $81.46M, a 8.18% increase from the previous quarter (Q2 2024), and a 27.81% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $75.3M, a 5.32% increase from the previous quarter (Q1 2024), and a 25.13% increase year-over-year (Q2 2023). TWST's quarterly revenue for Q1 2024 was $71.5M, a 6.80% increase from the previous quarter (Q4 2023), and a 31.81% increase year-over-year (Q1 2023).
What is Twist Bioscience’s revenue growth rate?
Twist Bioscience's revenue growth rate for the last 3 years (2021-2023) was 85.22%, and for the last 5 years (2019-2023) was 350.69%.
What are Twist Bioscience’s revenue streams?
Twist Bioscience's revenue streams in p 23 are Antibody Discovery, Dna And Biopharma Libraries, Ngs Tools, Oligo Pools, and Synthetic Genes. Antibody Discovery generated $23.17M in revenue, accounting 9.45% of the company's total revenue, down -4.13% year-over-year. Dna And Biopharma Libraries generated $10.2M in revenue, accounting 4.16% of the company's total revenue, up 65.90% year-over-year. Ngs Tools generated $123.71M in revenue, accounting 50.47% of the company's total revenue, up 24.56% year-over-year. Oligo Pools generated $14.49M in revenue, accounting 5.91% of the company's total revenue, up 16.62% year-over-year. Synthetic Genes generated $73.54M in revenue, accounting 30.00% of the company's total revenue, up 19.56% year-over-year.
What is Twist Bioscience’s main source of revenue?
For the fiscal year ending Sep 23, the largest source of revenue of Twist Bioscience was Ngs Tools. This segment made a revenue of $123.71M, representing 50.47% of the company's total revenue.